Clinical Trials
Braintumor Website

There are 9 trials:
Facility: Medical College of Wisconsin
NCT Trial Name# of Centers

NCT02670083

  CREAD Study: A Study of Crenezumab Versus Placebo to Evaluate the Efficacy and Safety in Participants With Prodromal to Mild Alzheimer's Disease (AD)
212

NCT01480479

  Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
206

NCT01351545

  A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
133

NCT00389181

  A Randomized Trial of Unruptured Brain AVMs
66

NCT01431326

  Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care
29

NCT02564198

  A Study of Ramucirumab (LY3009806) in Children With Refractory Solid Tumors
19

NCT02875314

  HeadStart4: Newly Diagnosed Children (<10 y/o) With Medulloblastoma and Other CNS Embryonal Tumors
14

NCT01898273

  Imaging Trial With I-124-CLR1404 in Patients With Newly Diagnosed or Recurrent Glioblastoma
9

NCT01016756

  Genetic Analysis of PHACE Syndrome (Hemangioma With Other Congenital Anomalies)
1



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2017 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740


Website Design By
World Wide Websites